Insiders who reported open-market trades in the last 12 months at the companies Jason Cavalier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jason Cavalier is a corporate insider, tracked as Principal Financial Officer of Lyra Therapeutics, Inc. (LYRA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jason Cavalier last file a Form 4?
The most recent primary Form 4 on record is dated 3 April 2026, one of 4 filings going back to 2024.
Has Jason Cavalier been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($9K) across all tracked filings.
Jason Cavalier is Principal Financial Officer of Lyra Therapeutics, Inc. (LYRA). 4 SEC Form 4 filings on record going back to 2024, most recently on 3 April 2026. Most recent open-market trade: sold $3K of LYRA on 8 January 2026. Lifetime open-market sales: $9K.
Recent transactions
4
The latest 4 SEC Form 4 transactions reported by Jason Cavalier.
InsiderAlpha's records for Jason Cavalier go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
